Is asymptomatic peripheral arterial disease associated with walking endurance in patients with COPD?

International Journal of COPD

Volumn 10, Issue 1, 2015, Pages 1487-1492

  Sun, Kuo Shao ^a   Lin, Ming Shian ^a   Chen, Yi Jen ^a   Chen, Yih Yuan ^b   Chen, Solomon Chih Cheng ^b   Chen, Wei ^a,c,d  

^a CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^c DA YEH UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

6 minute walk tests; Ankle brachial index; COPD; Peripheral arterial disease

Indexed keywords

6 MINUTE WALK TEST; ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DYSPNEA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OXYGEN COST DIAGRAM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSPECTIVE STUDY; PULSE OXIMETRY; RISK FACTOR; WALKING DIFFICULTY; CHI SQUARE DISTRIBUTION; COMPLICATION; EXERCISE TOLERANCE; LUNG; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIMETRY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICAL MODEL; VERY ELDERLY; VITAL CAPACITY; WALKING;

AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; ASYMPTOMATIC DISEASES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LINEAR MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIMETRY; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; VITAL CAPACITY; WALKING;

EID: 84938295960     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S85430     Document Type: Article

References (35)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773.
2. Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD. 2005;2(2):277–283.
3. O’Donnell DE, Laveneziana P. Dyspnea and activity limitation in COPD: mechanical factors. COPD. 2007;4(3):225–236.
4. Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23(133):345–349.
5. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry. 2004;58(1):65–70.
6. Wust RC, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis. 2007;2(3):289–300.
7. Weise B. [Pneumology rehabilitation 1999. Summary of statements of the American Thoracic Society in Am J Respir Crit Care Med 159 (19991) 1666–1682]. Pneumologie. 2000;54(5):215–217.
8. Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the towards a revolution in COPD health study. Chest. 2009;136(6):1456–1465.
9. Romme EA, Smeenk FW, Rutten EP, Wouters EF. Osteoporosis in chronic obstructive pulmonary disease. Expert Rev Respir Med. 2013;7(4):397–410.
10. Engström G, Hedblad B, Janzon L, Valind S. Respiratory decline in smokers and ex-smokers–an independent risk factor for cardiovascular disease and death. J Cardiovasc Risk. 2000;7(4):267–272.
11. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127(6):1952–1959.
12. Castagna O, Boussuges A, Nussbaum E, Marqueste L, Brisswalter J. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients. Eur J Cardiovasc Prev Rehabil. 2008;15(3):270–277.
13. Blum A, Simsolo C, Sirchan R, Haiek S. “Obesity paradox” in chronic obstructive pulmonary disease. Isr Med Assoc J. 2011;13(11):672–675.
14. Pecci R, De La Fuente Aguado J, Sanjurjo Rivo AB, Sanchez Conde P, Corbacho Abelaira M. Peripheral arterial disease in patients with chronic obstructive pulmonary disease. Int Angiol. 2012;31(5):444–453.
15. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94(11):3026–3049.
16. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25(6):1172–1181.
17. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA. 2004;292(4):453–461.
18. Lin MS, Hsu KY, Chen YJ, Chen CR, Chen CM, Chen W. Prevalence and risk factors of asymptomatic peripheral arterial disease in patients with COPD in Taiwan. PLoS One. 2013;8(5):e64714.
19. Johannessen A, Nilsen RM, Storebø M, Gulsvik A, Eagan T, Bakke P. Comparison of 2011 and 2007 global initiative for chronic obstructive lung disease guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med. 2013;188(1):51–59.
20. Lisboa BC, Barría PP, Yáñez VJ, Aguirre ZM, Díaz PO. [Six minutes walk for the assessment of patients with chronic obstructive pulmonary disease]. Rev Med Chil. 2008;136(8):1056–1064.
21. Nordanstig J, Broeren M, Hensäter M, Perlander A, Osterberg K, Jivegård L. Six-minute walk test closely correlates to “real-life” outdoor walking capacity and quality of life in patients with intermittent claudication. J Vasc Surg. 2014;60(2):404–409.
22. Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342.
23. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
24. McGavin CR, Artvinli M, Naoe H, McHardy GJ. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J. 1978;2(6132):241–243.
25. Chuang ML, Lee CH, Lin IF. Using the oxygen-cost diagram in ramp-slope selection for dyspneic patients. Intern Med. 2010;49(14):1325–1332.
26. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.
27. Mador MJ, Rodis A, Magalang UJ. Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD. Chest. 1995;107(6):1590–1597.
28. Blum A, Simsolo C, Sirchan R. Vascular responsiveness in patients with chronic obstructive pulmonary disease (COPD). Eur J Intern Med. 2014;25(4):370–373.
29. McDermott MM, Ferrucci L, Guralnik JM, et al. The ankle-brachial index is associated with the magnitude of impaired walking endurance among men and women with peripheral arterial disease. Vasc Med. 2010;15(4):251–257.
30. McDermott MM, Fried L, Simonsick E, Ling S, Guralnik JM. Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning the women’s health and aging study. Circulation. 2000;101(9):1007–1012.
31. Katsura H, Yamada K, Kida K. Usefulness of a linear analog scale questionnaire to measure health-related quality of life in elderly patients with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2003;51(8):1131–1135.
32. Ries AL. Minimally clinically important difference for the UCSD shortness of breath questionnaire, Borg Scale, and Visual Analog Scale. COPD. 2005;2(1):105–110.
33. Jones PW, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J. 2013;42(3):647–654.
34. Koblizek V, Pecen L, Zatloukal J, et al. Real-life GOLD 2011 implementation: the management of COPD lacks correct classification and adequate treatment. PLoS One. 2014;9(11):e111078.
35. Golpe R, Pérez-de-Llano LA, Méndez-Marote L, Veres-Racamonde A. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients. Respir Care. 2013;58(8):1329–1334.